🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal is to prospectively estimate the median PFS of African Ame...
Status
Completed
Location
Tulane University
Start Date
2017-07-10
Trial ID
NCT03098836
Treatments Being Tested
The purpose of this study is to evaluate systemic exposure of abiraterone a...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01516047
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
This is a phase II, open label, single center study to evaluate the efficac...
Status
Completed
Location
University of California, San Francisco
Start Date
2010-09-10
Trial ID
NCT01199146
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested
This is a phase 2, multicenter, open-label study to evaluate the efficacy o...
Status
Suspended
Location
UCSD Moores Cancer Center
Start Date
2025-09
Trial ID
NCT05361915
Treatments Being Tested